Galectin Therapeutics (GALT) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 32.17% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | -65.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.72% |
| Dec 31, 2025 | 30.51% |
| Sep 30, 2025 | 35.85% |
| Jun 30, 2025 | 41.82% |
| Mar 31, 2025 | 1.49% |
| Dec 31, 2024 | -80.79% |
| Sep 30, 2024 | -34.00% |
| Jun 30, 2024 | -42.66% |
| Mar 31, 2024 | 30.91% |
| Dec 31, 2023 | 43.78% |
| Sep 30, 2023 | 31.84% |
| Jun 30, 2023 | 27.35% |
| Mar 31, 2023 | 42.41% |
| Dec 31, 2022 | 43.68% |
| Sep 30, 2022 | -69.77% |
| Jun 30, 2022 | -29.36% |
| Mar 31, 2022 | -84.48% |
| Dec 31, 2021 | 53.53% |
| Sep 30, 2021 | 151.23% |
| Jun 30, 2021 | 18.53% |
| Mar 31, 2021 | -106.66% |
| Dec 31, 2020 | -11.51% |
| Sep 30, 2020 | -55.86% |
| Jun 30, 2020 | 17.24% |
| Mar 31, 2020 | -34.20% |
| Dec 31, 2019 | -60.04% |
| Sep 30, 2019 | 4.26% |
| Jun 30, 2019 | 127.51% |
| Mar 31, 2019 | 28.40% |
| Dec 31, 2018 | -34.18% |
| Sep 30, 2018 | 58.48% |
| Jun 30, 2018 | 61.07% |
| Mar 31, 2018 | 61.74% |
| Dec 31, 2017 | -23.50% |
| Sep 30, 2017 | 12.36% |
| Jun 30, 2017 | -27.66% |
| Mar 31, 2017 | -27.36% |
| Dec 31, 2016 | -42.61% |
| Sep 30, 2016 | -34.28% |
| Jun 30, 2016 | -33.93% |
| Mar 31, 2016 | -14.16% |
| Dec 31, 2015 | 67.16% |
| Sep 30, 2015 | -34.36% |
| Jun 30, 2015 | -11.00% |
| Mar 31, 2015 | -70.84% |
| Dec 31, 2014 | -10.25% |
| Sep 30, 2014 | -331.87% |
| Jun 30, 2014 | -59.86% |
| Mar 31, 2014 | 191.22% |
| Dec 31, 2013 | -36.87% |
| Sep 30, 2013 | 358.21% |